Scientists at Berkeley Lab’s Molecular Foundry have joined forces with a research team at Stanford to aim a gene-targeting, antiviral agent called PAC-MAN against COVID-19.
Scientists at Berkeley Lab’s Molecular Foundry have joined forces with a research team at Stanford to aim a gene-targeting, antiviral agent called PAC-MAN against COVID-19.
